Ketotifen
규격
34580-13-7CAS 번호
252-099-7EC 번호
2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-8-oneIUPAC 명칭
C19H19NOS화학식
309.4 g/mol분자량
ketotifen; 34580-13-7; Ketotifene; Ketotifeno; Ketotifenum; HC 20-511; DTXSID7023190; 4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one; X49220T18G; DTXCID203190; CHEBI:92511; 10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-; 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-10h-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one; Ketotiphene; Ketotiphen; 10-(1-methylpiperidin-4-ylidene)-5H-benzo[1,2]cyclohepta[3,4-b]thiophen-4-one; 10H-Benzo(4,5)cyclohepta(1,2-b)thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-; 10-(1-methylpiperidin-4-ylidene)-5H-benzo(1,2)cyclohepta(3,4-b)thiophen-4-one; 2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo(8.4.0.0^(3,7))tetradeca-1(10),3(7),4,11,13-pentaen-8-one; 2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),3(7),4,11,13-pentaen-8-one; RefChem:57862; 4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one; R06AX17; S01GX08; 252-099-7; Ketotifene [INN-French]; Ketotifenum [INN-Latin]; Ketotifeno [INN-Spanish]; Ketotifen (INN); 2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-8-one; HC 20511 fumarate; 4-(1-methylpiperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one; CHEMBL534; MFCD00599548; 4-(1-Methyl-4-piperidinylidene)-4H-benzo[4,5]cyclohepta[1,2-d]thiophene-10(9H)-one; NCGC00015580-08; KETOTIFEN [INN]; Ketotifen [INN:BAN]; 4-(1-Methyl-4-piperidylidene)-9-hydrobenzo[a]thiopheno[3,2-d][7]annulen-10-one; 4-(1-Methylpiperidin-4-ylidene)-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one; Ketotifene fumarate; Ketotifin; MLS002222254; Alaway (TN); CAS-34580-13-7; HSDB 7283; SMR001307257; EINECS 252-099-7; BRN 3983897; UNII-X49220T18G; (R)-Ketotifen; Spectrum_000426; Tocris-0784; KETOTIFEN [MI]; KETOTIFEN [HSDB]; Prestwick0_000371; Prestwick1_000371; Prestwick2_000371; Prestwick3_000371; Spectrum2_001198; Spectrum3_001382; Spectrum4_000805; Spectrum5_001395; KETOTIFEN [VANDF]; Lopac-K-2628; 4-(1-Methyl-piperidin-4-ylidene)-4,9-dihydro-1-thia-benzo[f]azulen-10-one; KETOTIFEN [WHO-DD]; SCHEMBL4436; Lopac0_000706; Oprea1_335550; Oprea1_553550; BSPBio_000521; BSPBio_002964; KBioGR_001289; KBioSS_000906; BIDD:GT0509; DivK1c_000111; SPBio_001275; SPBio_002442; BPBio1_000575; GTPL7206; orb1744252; SCHEMBL29356083; BDBM94597; cid_5282408; KBio1_000111; KBio2_000906; KBio2_003474; KBio2_006042; KBio3_002184; cid_45479747; NINDS_000111; GLXC-25233; HMS2090F16; US9138431, KETOTIFEN; US9333199, KETOTIFEN; ALBB-038658; HY-B0157; Tox21_110176; BDBM50002087; EBC-26727; EX-A15613; STK048448; AKOS000541268; Tox21_110176_1; CCG-204791; DB00920; SDCCGSBI-0050684.P005; 4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one; IDI1_000111; NCGC00015580-01; NCGC00015580-02; NCGC00015580-03; NCGC00015580-04; NCGC00015580-05; NCGC00015580-06; NCGC00015580-07; NCGC00015580-09; NCGC00015580-10; NCGC00015580-11; NCGC00015580-13; NCGC00015580-16; NCGC00015580-23; NCGC00022572-02; NCGC00022572-04; NCGC00022572-05; 10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-, (2E)-2-butenedioate (1:1); AC-15945; DA-54624; HC-20511; SY420976; SBI-0050684.P004; CAS-34580-14-8; AB00053575; CS-0013637; NS00009685; ST50002662; D08105; F97963; T73336; AB00053575-21; AB00053575_22; AB00053575_23; EN300-18530986; L000753; SR-01000000175; Q2458673; SR-01000000175-7; BRD-K28936863-051-05-8; BRD-K28936863-051-18-1; BRD-K28936863-051-31-4; BRD-K28936863-051-32-2; BRD-K28936863-051-33-0; KETOTIFEN HYDROGEN FUMARATE IMPURITY E [EP IMPURITY]; 10-(1-methyl-4-piperidinylidene)-5H-benzo[1,2]cyclohepta[3,4-b]thiophen-4-one; 10-(1-methyl-4-piperidylidene)-5H-benzo[[?]:[?]]cyclohepta[[?]]thiophen-4-one; 10-(1-methyl-4-piperidylidene)-5H-benzo[1,2]cyclohepta[3,4-b]thiophen-4-one;maleate; 4-(1-methyl-4-piperidylidene)-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one; 4-(1-Methyl-piperidin-4-ylidene)-4,9-dihydro-1-thia-benzo[f]azulen-10-one(Ketotifen); (Z)-2-butenedioate;10-(1-methyl-4-piperidinylidene)-5H-benzo[1,2]cyclohepta[3,4-b]thiophen-4-one; (Z)-but-2-enedioate;10-(1-methylpiperidin-4-ylidene)-5H-benzo[1,2]cyclohepta[3,4-b]thiophen-4-one; 116655-76-6; 2-(1-methyl-4-piperidylidene)-6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-8-one; 2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.0,3,7]tetradeca-1(10),3(7),4,11,13-pentaen-8-one; 4-(1-Methyl-4-piperidinylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one #; 4-(1-Methyl-piperidin-4-ylidene)-4,9-dihydro-1-thia-benzo[f]azulen-10-one(Ketotifen hydrogen malate); KETOTIFEN;10h-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one,4,9-dihydro-4-(1-methyl-4-piper;4-(1-Methyl-4-piperidinylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one;4,9-dihydro-4-(1-methyl-4-piperidinylidene)-10h-benzo(4,5)cyclohepta(1,2-b동의어
Ketotifen 함유 제품
ZASTEN 0,2 mg/ml SOLUCION ORALKETOTIFENO DERMOGEN 0,25 MG/ML COLIRIO EN SOLUCION EN ENVASE UNIDOSISKetosan-capKetofen-DropBronketKeronellKetofhexalZaditenNewatipene Ophthalmic SolutionDaenase Ophthalmic SolutionDatifen OphPrivent
1/3 페이지
Ketotifen 판매 기업
CT
Công ty cổ phần dược phẩm WealpharViet NamBC
Binex Co., LtdRepublic of KoreaYI
Young Il Pharm. Co., LtdRepublic of KoreaHA
Hexal AGGermanyAS
Alfasigma S.P.AItaly1/2 페이지